Naya Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.05 Cr
as on 16-12-2024
- Paid Up Capital ₹ 2.46 Cr
as on 16-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -13.33%
(FY 2022)
- Ebitda -34.38%
(FY 2022)
- Net Worth -9.23%
(FY 2022)
- Total Assets 809.67%
(FY 2022)
About Naya Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.05 Cr and a paid-up capital of Rs 2.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishna Kuchipudi, Snigdha Mothukuri, and Kuchipudi Vanaja serve as directors at the Company.
- CIN/LLPIN
U24100TG2020PTC142987
- Company No.
142987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Naya Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snigdha Mothukuri  | Additional Director | 12-Feb-2024 | Current |
| Krishna Kuchipudi | Additional Director | 02-Mar-2024 | Current |
| Kuchipudi Vanaja | Director | 19-Aug-2020 | Current |
Financial Performance of Naya Pharma.
Naya Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 13.33% decrease in profit. The company's net worth dipped by a decrease of 9.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naya Pharma?
Unlock access to Naya Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jeevan Scientific Technology LimitedActive 25 years 10 monthsKrishna Kuchipudi and Snigdha Mothukuri are mutual person
Jeevana Mitra Constructions LlpActive 5 years 3 monthsKrishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Nayas Laboratories Private LimitedActive 2 years 2 months
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Jstl Pharmaceutical Private LimitedActive 2 years 7 days
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
- Sm Therapeutics Private LimitedActive 11 months 4 days
Krishna Kuchipudi and Kuchipudi Vanaja are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Naya Pharma?
Naya Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
